nxp900
EGFR Mutated Non-small Cell Lung Cancer Patients
Nuvectis Pharma, Inc.Phase 1
—
Rating in progress
nxp900 in EGFR Mutated Non-small Cell Lung Cancer Patients is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active